Infantile spasms

Area of Science:

• Pediatric Neurology
• Epileptology
• Developmental Neuroscience

Background:

• Infantile spasms (IS) are a distinct seizure type and age-specific epilepsy syndrome.
• Classification has evolved, distinguishing seizure type (epileptic spasms) from epilepsy syndrome (West syndrome).
• Advances in neuroimaging and understanding pathophysiology are improving diagnostic yield.

Purpose of the Study:

• To review current understanding and management of infantile spasms.
• To highlight recent advances in diagnosis, treatment, and prognosis.
• To discuss the evolving classification and therapeutic landscape.

Main Methods:

• Review of recent literature on infantile spasms and West syndrome.
• Analysis of clinical, electrographic, and neuroimaging findings.
• Evaluation of current and emerging therapeutic options.

Main Results:

• Epileptic spasms and hypsarrhythmia have more detailed clinical and electrographic descriptions.
• Neuroimaging advances aid in identifying etiology and understanding pathophysiology.
• Vigabatrin is supported as first-line therapy; other agents like topiramate, lamotrigine, and zonisamide show promise.
• Adrenocorticotrophic hormone remains a common treatment; surgical options exist for select cases.
• Visual-field constriction is a concern with vigabatrin.

Conclusions:

• Prognosis for infantile spasms remains generally poor, but research offers hope.
• Identifying predictors of favorable prognosis is crucial.
• Advances in understanding pathophysiology may lead to safer, more effective therapies.
• Improved long-term outcomes are anticipated with continued research and therapeutic innovation.